These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Quantification of melanoma micrometastases in sentinel lymph nodes using real-time RT-PCR. Giese T; Engstner M; Mansmann U; Hartschuh W; Arden B J Invest Dermatol; 2005 Mar; 124(3):633-7. PubMed ID: 15737205 [TBL] [Abstract][Full Text] [Related]
10. Reproducibility of detection of tyrosinase and MART-1 transcripts in the peripheral blood of melanoma patients: a quality control study using real-time quantitative RT-PCR. de Vries TJ; Fourkour A; Punt CJ; van de Locht LT; Wobbes T; van den Bosch S; de Rooij MJ; Mensink EJ; Ruiter DJ; van Muijen GN Br J Cancer; 1999 May; 80(5-6):883-91. PubMed ID: 10360670 [TBL] [Abstract][Full Text] [Related]
11. Circulating tyrosinase and MART-1 mRNA does not independently predict relapse or survival in patients with AJCC stage I-II melanoma. Schmidt H; Sorensen BS; Sjoegren P; Christensen IJ; Fode K; Larsen J; Nexo E; von der Maase H J Invest Dermatol; 2006 Apr; 126(4):849-54. PubMed ID: 16410782 [TBL] [Abstract][Full Text] [Related]
12. Correlation of positive RT-PCR for tyrosinase in peripheral blood of malignant melanoma patients with clinical stage, survival and other risk factors. Proebstle TM; Jiang W; Högel J; Keilholz U; Weber L; Voit C Br J Cancer; 2000 Jan; 82(1):118-23. PubMed ID: 10638977 [TBL] [Abstract][Full Text] [Related]
13. Molecular tumor markers in the blood: early prediction of disease outcome in melanoma patients treated with a melanoma vaccine. Wascher RA; Morton DL; Kuo C; Elashoff RM; Wang HJ; Gerami M; Hoon DS J Clin Oncol; 2003 Jul; 21(13):2558-63. PubMed ID: 12829676 [TBL] [Abstract][Full Text] [Related]
14. Tyrosinase mRNA RT-PCR analysis as an additional diagnostic tool for the identification of melanoma cells in biological fluid samples other than blood: a preliminary report. Savoia P; Quaglino P; Osella-Abate S; Comessatti A; Nardò T; Bernengo MG Int J Biol Markers; 2005; 20(1):11-7. PubMed ID: 15832768 [TBL] [Abstract][Full Text] [Related]
15. Pathologic assessment of melanoma sentinel nodes: a role for molecular analysis using quantitative real-time reverse transcription-PCR for MART-1 and tyrosinase messenger RNA. Abrahamsen HN; Sorensen BS; Nexo E; Hamilton-Dutoit SJ; Larsen J; Steiniche T Clin Cancer Res; 2005 Feb; 11(4):1425-33. PubMed ID: 15746042 [TBL] [Abstract][Full Text] [Related]
16. Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma. Scoggins CR; Ross MI; Reintgen DS; Noyes RD; Goydos JS; Beitsch PD; Urist MM; Ariyan S; Davidson BS; Sussman JJ; Edwards MJ; Martin RC; Lewis AM; Stromberg AJ; Conrad AJ; Hagendoorn L; Albrecht J; McMasters KM J Clin Oncol; 2006 Jun; 24(18):2849-57. PubMed ID: 16782924 [TBL] [Abstract][Full Text] [Related]
17. Serial follow-up and the prognostic significance of reverse transcriptase-polymerase chain reaction--staged sentinel lymph nodes from melanoma patients. Kammula US; Ghossein R; Bhattacharya S; Coit DG J Clin Oncol; 2004 Oct; 22(19):3989-96. PubMed ID: 15459222 [TBL] [Abstract][Full Text] [Related]
18. Quantitative RT-PCR assessment of melanoma cells in peripheral blood during immunotherapy for metastatic melanoma. Schmidt H; Sørensen BS; von der Maase H; Bang C; Agger R; Hokland M; Nexo E Melanoma Res; 2002 Dec; 12(6):585-92. PubMed ID: 12459648 [TBL] [Abstract][Full Text] [Related]
19. Molecular staging by multimarker reverse transcriptase-polymerase chain reaction assay of lymphatic drainage and blood from melanoma patients after lymph node dissection. Rutkowski P; Nowecki ZI; Kulik J; Ruka W; Siedlecki JA Melanoma Res; 2008 Aug; 18(4):246-52. PubMed ID: 18626308 [TBL] [Abstract][Full Text] [Related]
20. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases. Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]